VY-3-135

CAS No. 1824637-41-3

VY-3-135( —— )

Catalog No. M28868 CAS No. 1824637-41-3

VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 188 In Stock
5MG 187 In Stock
10MG 312 In Stock
25MG 528 In Stock
50MG 711 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VY-3-135
  • Note
    Research use only, not for human use.
  • Brief Description
    VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.
  • Description
    VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Fatty Acid Synthase
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1824637-41-3
  • Formula Weight
    429.51
  • Molecular Formula
    C26H27N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (116.41 mM)
  • SMILES
    CCn1c(cc(cc2)C(NC[C@@H](C)O)=O)c2nc1C(c1ccccc1)(c1ccccc1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hussein H, Abu-Zeid K M. 2-hydrazinopyrimidines as precursors for azolopyri-midìnes and pyrimidotriazines expected antimicrobial activity[J]. Egyptian Journal of Chemistry, 2007, 50(6):725-737.
molnova catalog
related products
  • ELN484228

    ELN484228 is a blocker of α-synuclein which is a key protein in Parkinson’s disease.

  • FT113

    FT113 is a novel potent inhibitor of fatty acid synthase (fasn IC50 : 213 nM)and exhibits anti-cancer activity.

  • UCM05

    UCM05 (G28UCM) is a potent inhibitor of fatty acid synthase (FASN) with efficacy against HER2+ breast cancer xenografts, including cell lines resistant to anti-HER2 drugs .